Similar Papers

Paper Title
Journal
Date
Author
Outcome and Toxicity for Patients Treated with Intensity Modulated Radiation Therapy for Localized Prostate Cancer
Sujay A Vora ... Scott K Swanson
Journal of Urology | VOL. 190
Sujay A Vora, et. al.Sujay A Vora ... Scott K Swanson
12 Feb 2013
Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer
A Loblaw
Clinical Oncology | VOL. 32
A LoblawA Loblaw
28 Nov 2019
Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1).
Satoru Ueno ... Atsushi Mizokami
Prostate International | VOL. 6
Satoru Ueno, et. al.Satoru Ueno ... Atsushi Mizokami
03 Jun 2017
Multimodal treatment in focal therapy for localized prostate cancer using concomitant short-term androgen deprivation therapy: the ENHANCE prospective pilot study.
Giancarlo Marra ... Xavier Cathelineau
Minerva Urologica e Nefrologica | VOL. 71
Giancarlo Marra, et. al.Giancarlo Marra ... Xavier Cathelineau
06 Sep 2019
View more papers

More From: European Urology

Paper Title
Journal
Date
Author
Editorial Board
-
European Urology | VOL. 87
--
01 Feb 2025
Platinum Hall of Fame
-
European Urology | VOL. 87
--
01 Feb 2025
Re: Guillaume Ploussard, Patrick Coloby, Thierry Chevallier, et al. Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.11.006.
Jason Koehler ... Abhinav Sidana
European urology | VOL. -
Jason Koehler, et. al.Jason Koehler ... Abhinav Sidana
24 Jan 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.
Axel Bex ... Grant D Stewart
European urology | VOL. -
Axel Bex, et. al.Axel Bex ... Grant D Stewart
23 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.